Event

A One-Day Pharmacology Conference
Sponsored by the APN Council and Pharmacy Department

Held virtually on Zoom and Live at Cooperman Barnabas Medical Center
Islami Auditorium, Islami B, 94 Old Short Hills Road, Livingston, NJ 07039

Target Audience
RWJBarnabas Health Nurses, Physicians, Residents, Advance Practice Providers, and Allied Health Staff

Learning Objectives
At the conclusion of the conference, the attendee will gain knowledge and understanding regarding:

• guideline-directed medical therapy for heart failure management and guideline-directed medical therapy
• treatment for community acquired pneumonia (CAP), hospital acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) plus learn how to utilize the antibiogram
• common conditions and treatments in psychiatric/mental health
• common anticoagulants and role of reversal agents in line with CBMC policies
• inpatient management of diabetes and transitions of care pearls
• common terminology when caring for transgender patients, impact of hormone therapy on treatment, and current medication reconciliation and practices at CBMC
• complementary and alternative approaches to pain management including traditional approaches, opioids, plus complementary and alternative methods including cannabis
• caring for the renal transplant patient and renal transplant medications.

Registration
This event is free, but registration is required.

Agenda

Breakfast and lunch will be provided.

7:00 a.m. | Registration, Welcome, Breakfast

7:30 a.m. | Heart Failure Management and Treatment
Ruichao Cheng, APN, Lead Cardiovascular APN

8:00 a.m. | Antimicrobial Optimization in Patients with Pneumonia
Yash Solanki, PharmD, PGY1 Pharmacy Resident
Andras Farkas, PharmD, Senior Clinical Pharmacist, Infectious Diseases

9:00 a.m. | Psychiatric Medications: The Basics
Kristina Logan, PharmD, PGY1 Pharmacy Resident
Arielle Hopkins, PharmD, BCPS, Clinical Pharmacist, Internal Medicine; Clinical Assistant Professor, Ernest Mario College of Pharmacy, Rutgers University

10:00 a.m. | Break

10:15 a.m. | Considerations for Anticoagulation and Reversal
Gabriela Alvarez, PharmD, PGY2 Geriatric Pharmacy Resident
Angela Antoniello, PharmD, BCPS, BCCCP, BCEMP, Senior Clinical Pharmacist, Emergency Medicine

11:15 a.m. | Inpatient Management of diabetes
Ljubica Minova, PharmD, Senior Clinical Pharmacist, Geriatrics

12:30 pm | Lunch

1:30 p.m. | Caring for Transgender Patients
Patrick Koslecki, Director, Diversity, Equity and Inclusion
Jason Carlson, CPhT, Medication Reconciliation Pharmacy Technician

2:30 p.m. | Complementary and Alternative Approaches to Pain Management
Jess Bente, PharmD, BCPS, BCGP, Assistant Director, Pharmacy for Clinical Services

3:30 p.m. | Caring for the Renal Transplant patient
Homero Paniagua, DNP, APN.C., Clinical Manager, Post-Transplant Services

4:00 p.m. | Evaluation, CEU distribution

-------------------------------------------------

Continuing Medical Education Credit

AMA Credit Designation Statement: Cooperman Barnabas Medical Center designates this education activity for a maximum of 7.0 AMA PRA Category 1 Credit(s) ™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy: It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity, and scientific rigor in all CME sponsored education activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.

Faculty Disclosures: No relevant financial relationship(s) or disclose any relationship(s) that exist.

Acknowledgement of Commercial Support: No commercial support was provided for this activity.

“Patient Safety Committee Work Product – Confidential Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H – 12.25b. & N.J.A.C. 8:43E – 10.”